Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Can HIV Vaccine Initiative)

McMaster University

$100,000.00

Functional correlate of mucosal antibody response to HIV infection in blood.

FY 2008-09

Summary
Most infections with HIV worldwide are sexually transmitted and women are the most frequently infected. In order to protect against HIV infection and AIDS, vaccines must be effective at blocking entry of the virus. In sexual transmission, HIV enters through the mucosal surfaces of the body. These surfaces can respond with a specific type of antibody, the IgA type. Thus, when developing new HIV vaccines, we must be able to measure the amount and quality of mucosal IgA antibody against HIV. Studies have shown that women who are able to resist HIV infection have IgA antibodies against HIV, while those that become infected have little or no IgA. Unfortunately, many such studies have conflicting results or are hampered by the difficulty in sampling and testing for these IgA antibodies, using fluid samples from the mucosal surfaces. A test in blood would be much more simple, reliable, and useful. We propose to use the circulating immune cells in blood responsible for IgA antibody production, as a reliable means to measure the amount and quality of mucosal IgA antibody against HIV. In our proposal, we will be able to determine if IgA antibody was produced, how much response is evident, and how well the IgA antibody can inhibit the virus. We will look at HIV resistant and HIV infected people to see if any differences exist in mucosal IgA antibodies, obtained from the blood cells. These studies will provide valuable data and will prove the feasibility of measuring mucosal IgA responses, using blood samples.
Program
Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Can HIV Vaccine Initiative)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
174750
Name
Snider Denis P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
HIV Vaccine Discovery
Projecttitle
Functional correlate of mucosal antibody response to HIV infection in blood.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Can HIV Vaccine Initiative)
Keyworddelim
Cell Culture; Elispot; Flow Cytometry; Hiv; Vaccine
Abstract
Most infections with HIV worldwide are sexually transmitted and women are the most frequently infected. In order to protect against HIV infection and AIDS, vaccines must be effective at blocking entry of the virus. In sexual transmission, HIV enters through the mucosal surfaces of the body. These surfaces can respond with a specific type of antibody, the IgA type. Thus, when developing new HIV vaccines, we must be able to measure the amount and quality of mucosal IgA antibody against HIV. Studies have shown that women who are able to resist HIV infection have IgA antibodies against HIV, while those that become infected have little or no IgA. Unfortunately, many such studies have conflicting results or are hampered by the difficulty in sampling and testing for these IgA antibodies, using fluid samples from the mucosal surfaces. A test in blood would be much more simple, reliable, and useful. We propose to use the circulating immune cells in blood responsible for IgA antibody production, as a reliable means to measure the amount and quality of mucosal IgA antibody against HIV. In our proposal, we will be able to determine if IgA antibody was produced, how much response is evident, and how well the IgA antibody can inhibit the virus. We will look at HIV resistant and HIV infected people to see if any differences exist in mucosal IgA antibodies, obtained from the blood cells. These studies will provide valuable data and will prove the feasibility of measuring mucosal IgA responses, using blood samples.
Competitiondate
200811
Approvedterm2
1 yr 0 mth
Pinamesdelim
Snider, Denis P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~